Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancer.

Details

Language :

English

ISSN :

15560864

Volume :

7

Issue :

3

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

108169164

Full Text :

https://doi.org/10.1097/jto.0b013e31823f459c